(Total Views: 198)
Posted On: 04/20/2017 11:34:50 AM
Post# of 2218
$LRGR LRGR (Luminar Media Group, Inc)
http://www.luminarinc.com
LRGR's initial efforts will focus on launching its innovative therapy device - the TherOZap™ - in the United States with additional markets to follow closely.
SO WHAT IS THE THEROZAP?
The patent-pending TherOZap™ is a next generation thermal therapy insect device that reduces the inflammatory response, relieving the symptoms of pain, itch and inflammation associated with bites and stings.
TherOZap™ device.
With that, came an agreement has been signed with the University Health Network to test Therozap™ against the Zika and West Nile viruses.
Rob Fia, CEO commented, “We are very excited with the TherOZap™ working prototype. Jenex looks forward to working with UHN to begin the initial testing to determine the effectiveness of the device at inactivating both the Zika and West Nile viruses."
http://www.luminarinc.com
LRGR's initial efforts will focus on launching its innovative therapy device - the TherOZap™ - in the United States with additional markets to follow closely.
SO WHAT IS THE THEROZAP?
The patent-pending TherOZap™ is a next generation thermal therapy insect device that reduces the inflammatory response, relieving the symptoms of pain, itch and inflammation associated with bites and stings.
TherOZap™ device.
With that, came an agreement has been signed with the University Health Network to test Therozap™ against the Zika and West Nile viruses.
Rob Fia, CEO commented, “We are very excited with the TherOZap™ working prototype. Jenex looks forward to working with UHN to begin the initial testing to determine the effectiveness of the device at inactivating both the Zika and West Nile viruses."
(0)
(0)
